|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
* C-alpha coords only
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immunoglobulin
|
 |
|
Title:
|
 |
Model of human iga1 determined by solution scattering curve-fitting and homology modelling
|
|
Structure:
|
 |
Iga1. Chain: a, b. Fragment: chains a and b, heavy, chains c and d, light. Iga1. Chain: c, d. Fragment: chains a and b, heavy, chains c and d, light
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Other_details: see primary reference for more details. Other_details: see primary reference for more details
|
|
Authors:
|
 |
M.K.Boehm,J.M.Woof,M.A.Kerr,S.J.Perkins
|
Key ref:
|
 |
M.K.Boehm
et al.
(1999).
The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
J Mol Biol,
286,
1421-1447.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
23-Dec-98
|
Release date:
|
15-Jun-99
|
|
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
286:1421-1447
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
|
|
M.K.Boehm,
J.M.Woof,
M.A.Kerr,
S.J.Perkins.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human immunoglobulin A (IgA) is an abundant antibody that mediates immune
protection at mucosal surfaces as well as in plasma. The IgA1 isotype contains
two four-domain Fab fragments and a four-domain Fc fragment analogous to that in
immunoglobulin G (IgG), linked by a glycosylated hinge region made up of 23
amino acid residues from each of the heavy chains. IgA1 also has two 18 residue
tailpieces at the C terminus of each heavy chain in the Fc fragment. X-ray
scattering using H2O buffers and neutron scattering using 100 % 2H2O buffers
were performed on monomeric IgA1 and a recombinant IgA1 that lacks the tailpiece
(PTerm455). The radii of gyration RG from Guinier analyses were similar at
6.11-6.20 nm for IgA1 and 5.84-6.16 nm for PTerm455, and their cross-sectional
radii of gyration RXS were also similar. The similarity of the RG and RXS values
suggests that the tailpiece of IgA1 is not extended outwards in solution. The
IgA1 RG values are higher than those for IgG, and the distance distribution
function P(r) showed two distinct peaks, whereas a single peak was observed for
IgG. Both results show that the hinge of IgA1 results in an extended Fab and Fc
arrangement that is different from that in IgG. Automated curve-fit searches
constrained by homology models for the Fab and Fc fragments were used to model
the experimental IgA1 scattering curves. A translational search to optimise the
relative arrangement of the Fab and Fc fragments held in a fixed orientation
resembling that in IgG was not successful in fitting the scattering data. A new
molecular dynamics curve-fit search method generated IgA1 hinge structures to
which the Fab and Fc fragments could be connected in any orientation. A search
based on these identified a limited family of IgA1 structures that gave good
curve fits to the experimental data. These contained extended hinges of length
about 7 nm that positioned the Fab-to-Fab centre-to-centre separation 17 nm
apart while keeping the corresponding Fab-to-Fc separation at 9 nm. The
resulting extended T-shaped IgA1 structures are distinct from IgG structures
previously determined by scattering and crystallography which have Fab-to-Fab
and Fab-to-Fc centre-to-centre separations of 7-9 nm and 6-8 nm, respectively.
It was concluded that the IgA1 hinge is structurally distinct from that in IgG,
and this results in a markedly different antibody structure that may account for
a unique immune role of monomeric IgA1 in plasma and mucosa.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Schematic diagram of the Ig fold domains in human
IgA1 and IgG1. Each heavy chain contains the V[H], C[H]1, C[H]2
and C[H]3 domains, and each light chain contains the V[L]and
C[L]domains, each of which is represented by a rectangle. The
four-domain Fab fragments are linked to the four-domain Fc
fragment by a 23 residue hinge in IgA1. The C terminus of each
IgA1 heavy chain contains an 18 residue tailpiece (broken line).
The hinge of IgG1 is one residue shorter and there is no
tailpiece. Each Ig fold contains a conserved internal Cys-Cys
disulphide bridge (S-S). The C[H]1 domain of IgA1 has an
additional disulphide bridge between Cys196-Cys220. The heavy
and light chains of IgA1 are linked between Cys133 in the C[H]1
domain, and the C-terminal Cys residue of the light chain. The
heavy and light chains of IgG1 are linked by a Cys residue in
the hinge and the C-terminal Cys residue of the light chain. In
IgA1, Cys241 and Cys242 in the hinge and Cys299 and Cys301 in
the C[H]2 domain form intra and inter-heavy chain disulphide
bridges. In IgG1, two Cys residues in the hinge form two
inter-chain bridges. In IgA1, Cys311 on the C[H]2 domain and
Cys471 in the tailpiece are shown free. IgA1 has two N-linked
oligosaccharide sites on β-strand B of the C[H]2 domain and on
the tailpiece (•). That on the C[H]2 domain of IgA1 is at a
different position to that on the C[H]2 domain of IgG1 which
occupies a central cavity in the IgG1 Fc structure and which is
conserved in the other human Ig classes. IgA1 also has five
O-linked oligosaccharide sites in the hinge (â—‹) which are not
present in IgG1. PTerm455 is a recombinant IgA1 molecule which
lacks the tailpiece.
|
 |
Figure 4.
Figure 4. Distance distribution functions P (r) for PTerm455,
human IgA1 and bovine IgG2. (a) PTerm455 using neutron data
measured at 2.4 mg/ml, for which M1 and M2 occur at 4.0 nm and
8.7 nm, respectively, and L is 20 nm. (b) IgA1 using X-ray data
measured at 2.1 mg/ml, for which the peaks M1 and M2 occur at
3.7 nm and 8.9 nm, respectively, and the length L is 21 nm. (c)
Bovine IgG2 using neutron data [Mayans et al 1995], for which M
occurs at 5.4 to 5.7 nm, and L is 16 nm.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1999,
286,
1421-1447)
copyright 1999.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
Google scholar
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Papista,
L.Berthelot,
and
R.C.Monteiro
(2011).
Dysfunctions of the Iga system: a common link between intestinal and renal diseases.
|
| |
Cell Mol Immunol,
8,
126-134.
|
 |
|
|
|
|
 |
S.J.Perkins,
R.Nan,
K.Li,
S.Khan,
and
Y.Abe
(2011).
Analytical ultracentrifugation combined with X-ray and neutron scattering: Experiment and modelling.
|
| |
Methods,
54,
181-199.
|
 |
|
|
|
|
 |
S.M.Khor,
G.Liu,
C.Fairman,
S.G.Iyengar,
and
J.J.Gooding
(2011).
The importance of interfacial design for the sensitivity of a label-free electrochemical immuno-biosensor for small organic molecules.
|
| |
Biosens Bioelectron,
26,
2038-2044.
|
 |
|
|
|
|
 |
K.Li,
J.Gor,
and
S.J.Perkins
(2010).
Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3.
|
| |
Biochem J,
431,
63-72.
|
 |
|
|
|
|
 |
M.Hammel,
Y.Yu,
B.L.Mahaney,
B.Cai,
R.Ye,
B.M.Phipps,
R.P.Rambo,
G.L.Hura,
M.Pelikan,
S.So,
R.M.Abolfath,
D.J.Chen,
S.P.Lees-Miller,
and
J.A.Tainer
(2010).
Ku and DNA-dependent protein kinase dynamic conformations and assembly regulate DNA binding and the initial non-homologous end joining complex.
|
| |
J Biol Chem,
285,
1414-1423.
|
 |
|
|
|
|
 |
M.J.Lewis,
B.Wagner,
R.M.Irvine,
and
J.M.Woof
(2010).
IgA in the horse: cloning of equine polymeric Ig receptor and J chain and characterization of recombinant forms of equine IgA.
|
| |
Mucosal Immunol,
3,
610-621.
|
 |
|
|
|
|
 |
P.L.Tran,
J.R.Gamboa,
D.J.You,
and
J.Y.Yoon
(2010).
FRET detection of Octamer-4 on a protein nanoarray made by size-dependent self-assembly.
|
| |
Anal Bioanal Chem,
398,
759-768.
|
 |
|
|
|
|
 |
R.C.Monteiro
(2010).
Role of IgA and IgA fc receptors in inflammation.
|
| |
J Clin Immunol,
30,
1-9.
|
 |
|
|
|
|
 |
R.C.Monteiro
(2010).
The role of IgA and IgA Fc receptors as anti-inflammatory agents.
|
| |
J Clin Immunol,
30,
S61-S64.
|
 |
|
|
|
|
 |
S.Lohse,
M.Peipp,
T.Beyer,
T.Valerius,
and
M.Dechant
(2010).
Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodies.
|
| |
Arch Immunol Ther Exp (Warsz),
58,
303-312.
|
 |
|
|
|
|
 |
Y.Abe,
J.Gor,
D.G.Bracewell,
S.J.Perkins,
and
P.A.Dalby
(2010).
Masking of the Fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy.
|
| |
Biochem J,
432,
101-111.
|
 |
|
|
|
|
 |
A.Bonner,
A.Almogren,
P.B.Furtado,
M.A.Kerr,
and
S.J.Perkins
(2009).
Location of secretory component on the Fc edge of dimeric IgA1 reveals insight into the role of secretory IgA1 in mucosal immunity.
|
| |
Mucosal Immunol,
2,
74-84.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Bonner,
A.Almogren,
P.B.Furtado,
M.A.Kerr,
and
S.J.Perkins
(2009).
The Nonplanar Secretory IgA2 and Near Planar Secretory IgA1 Solution Structures Rationalize Their Different Mucosal Immune Responses.
|
| |
J Biol Chem,
284,
5077-5087.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.D.Ramsey,
M.L.Gill,
T.J.Kamerzell,
E.S.Price,
S.B.Joshi,
S.M.Bishop,
C.N.Oliver,
and
C.R.Middaugh
(2009).
Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability.
|
| |
J Pharm Sci,
98,
2432-2447.
|
 |
|
|
|
|
 |
S.J.Perkins,
A.I.Okemefuna,
R.Nan,
K.Li,
and
A.Bonner
(2009).
Constrained solution scattering modelling of human antibodies and complement proteins reveals novel biological insights.
|
| |
J R Soc Interface,
6,
S679-S696.
|
 |
|
|
|
|
 |
T.A.Johnson,
J.Qiu,
A.G.Plaut,
and
T.Holyoak
(2009).
Active-site gating regulates substrate selectivity in a chymotrypsin-like serine protease the structure of haemophilus influenzae immunoglobulin A1 protease.
|
| |
J Mol Biol,
389,
559-574.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.F.Pease,
J.T.Elliott,
D.H.Tsai,
M.R.Zachariah,
and
M.J.Tarlov
(2008).
Determination of protein aggregation with differential mobility analysis: application to IgG antibody.
|
| |
Biotechnol Bioeng,
101,
1214-1222.
|
 |
|
|
|
|
 |
M.M.Gomes,
S.B.Wall,
K.Takahashi,
J.Novak,
M.B.Renfrow,
and
A.B.Herr
(2008).
Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.
|
| |
Biochemistry,
47,
11285-11299.
|
 |
|
|
|
|
 |
S.J.Forbes,
M.Eschmann,
and
N.J.Mantis
(2008).
Inhibition of Salmonella enterica serovar typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody.
|
| |
Infect Immun,
76,
4137-4144.
|
 |
|
|
|
|
 |
A.Bonner,
C.Perrier,
B.Corthésy,
and
S.J.Perkins
(2007).
Solution structure of human secretory component and implications for biological function.
|
| |
J Biol Chem,
282,
16969-16980.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.D.Putnam,
M.Hammel,
G.L.Hura,
and
J.A.Tainer
(2007).
X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution.
|
| |
Q Rev Biophys,
40,
191-285.
|
 |
|
|
|
|
 |
J.N.Arnold,
M.R.Wormald,
R.B.Sim,
P.M.Rudd,
and
R.A.Dwek
(2007).
The impact of glycosylation on the biological function and structure of human immunoglobulins.
|
| |
Annu Rev Immunol,
25,
21-50.
|
 |
|
|
|
|
 |
T.N.Kazeeva,
and
A.B.Shevelev
(2007).
Unknown functions of immunoglobulins A.
|
| |
Biochemistry (Mosc),
72,
485-494.
|
 |
|
|
|
|
 |
Y.Lu,
S.E.Harding,
T.E.Michaelsen,
E.Longman,
K.G.Davis,
A.Ortega,
J.G.Grossmann,
I.Sandlie,
and
J.García de la Torre
(2007).
Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation.
|
| |
Biophys J,
93,
3733-3744.
|
 |
|
|
|
|
 |
A.Johs,
M.Hammel,
I.Waldner,
R.P.May,
P.Laggner,
and
R.Prassl
(2006).
Modular structure of solubilized human apolipoprotein B-100. Low resolution model revealed by small angle neutron scattering.
|
| |
J Biol Chem,
281,
19732-19739.
|
 |
|
|
|
|
 |
J.M.Woof,
and
M.A.Kerr
(2006).
The function of immunoglobulin A in immunity.
|
| |
J Pathol,
208,
270-282.
|
 |
|
|
|
|
 |
M.M.Gomes,
and
A.B.Herr
(2006).
IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.
|
| |
Springer Semin Immunopathol,
28,
383-395.
|
 |
|
|
|
|
 |
Y.Lu,
E.Longman,
K.G.Davis,
A.Ortega,
J.G.Grossmann,
T.E.Michaelsen,
J.G.de la Torre,
and
S.E.Harding
(2006).
Crystallohydrodynamics of protein assemblies: Combining sedimentation, viscometry, and x-ray scattering.
|
| |
Biophys J,
91,
1688-1697.
|
 |
|
|
|
|
 |
I.von Ossowski,
J.T.Eaton,
M.Czjzek,
S.J.Perkins,
T.P.Frandsen,
M.Schülein,
P.Panine,
B.Henrissat,
and
V.Receveur-Bréchot
(2005).
Protein disorder: conformational distribution of the flexible linker in a chimeric double cellulase.
|
| |
Biophys J,
88,
2823-2832.
|
 |
|
|
|
|
 |
J.M.Woof,
and
J.Mestecky
(2005).
Mucosal immunoglobulins.
|
| |
Immunol Rev,
206,
64-82.
|
 |
|
|
|
|
 |
M.V.Petoukhov,
and
D.I.Svergun
(2005).
Global rigid body modeling of macromolecular complexes against small-angle scattering data.
|
| |
Biophys J,
89,
1237-1250.
|
 |
|
|
|
|
 |
F.E.Johansen,
and
P.Brandtzaeg
(2004).
Transcriptional regulation of the mucosal IgA system.
|
| |
Trends Immunol,
25,
150-157.
|
 |
|
|
|
|
 |
J.M.Woof,
and
D.R.Burton
(2004).
Human antibody-Fc receptor interactions illuminated by crystal structures.
|
| |
Nat Rev Immunol,
4,
89-99.
|
 |
|
|
|
|
 |
J.M.Woof,
and
M.A.Kerr
(2004).
IgA function--variations on a theme.
|
| |
Immunology,
113,
175-177.
|
 |
|
|
|
|
 |
A.Almogren,
B.W.Senior,
L.M.Loomes,
and
M.A.Kerr
(2003).
Structural and functional consequences of cleavage of human secretory and human serum immunoglobulin A1 by proteinases from Proteus mirabilis and Neisseria meningitidis.
|
| |
Infect Immun,
71,
3349-3356.
|
 |
|
|
|
|
 |
F.Carlsson,
K.Berggård,
M.Stålhammar-Carlemalm,
and
G.Lindahl
(2003).
Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein.
|
| |
J Exp Med,
198,
1057-1068.
|
 |
|
|
|
|
 |
L.Royle,
A.Roos,
D.J.Harvey,
M.R.Wormald,
D.van Gijlswijk-Janssen,
e.l.-.R.M.Redwan,
I.A.Wilson,
M.R.Daha,
R.A.Dwek,
and
P.M.Rudd
(2003).
Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems.
|
| |
J Biol Chem,
278,
20140-20153.
|
 |
|
|
|
|
 |
M.R.Batten,
B.W.Senior,
M.Kilian,
and
J.M.Woof
(2003).
Amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by streptococcal IgA1 proteases.
|
| |
Infect Immun,
71,
1462-1469.
|
 |
|
|
|
|
 |
R.C.Monteiro,
and
J.G.Van De Winkel
(2003).
IgA Fc receptors.
|
| |
Annu Rev Immunol,
21,
177-204.
|
 |
|
|
|
|
 |
R.J.Pleass,
P.K.Dehal,
M.J.Lewis,
and
J.M.Woof
(2003).
Limited role of charge matching in the interaction of human immunoglobulin A with the immunoglobulin A Fc receptor (Fc alpha RI) CD89.
|
| |
Immunology,
109,
331-335.
|
 |
|
|
|
|
 |
N.Feng,
J.A.Lawton,
J.Gilbert,
N.Kuklin,
P.Vo,
B.V.Prasad,
and
H.B.Greenberg
(2002).
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.
|
| |
J Clin Invest,
109,
1203-1213.
|
 |
|
|
|
|
 |
T.Areschoug,
S.Linse,
M.Stålhammar-Carlemalm,
L.O.Hedén,
and
G.Lindahl
(2002).
A proline-rich region with a highly periodic sequence in Streptococcal beta protein adopts the polyproline II structure and is exposed on the bacterial surface.
|
| |
J Bacteriol,
184,
6376-6383.
|
 |
|
|
|
|
 |
H.C.Morton,
C.J.Howard,
A.K.Storset,
and
P.Brandtzaeg
(2001).
Identification of residues within the extracellular domain 1 of bovine Fc gamma 2R essential for binding bovine IgG2.
|
| |
J Biol Chem,
276,
47794-47800.
|
 |
|
|
|
|
 |
M.Dechant,
and
T.Valerius
(2001).
IgA antibodies for cancer therapy.
|
| |
Crit Rev Oncol Hematol,
39,
69-77.
|
 |
|
|
|
|
 |
M.van Egmond,
C.A.Damen,
A.B.van Spriel,
G.Vidarsson,
E.van Garderen,
and
J.G.van de Winkel
(2001).
IgA and the IgA Fc receptor.
|
| |
Trends Immunol,
22,
205-211.
|
 |
|
|
|
|
 |
P.V.Afonin,
A.V.Fokin,
I.N.Tsygannik,
I.Y.Mikhailova,
L.V.Onoprienko,
I.I.Mikhaleva,
V.T.Ivanov,
T.Y.Mareeva,
V.A.Nesmeyanov,
N.Li,
W.A.Pangborn,
W.L.Duax,
and
V.Z.Pletnev
(2001).
Crystal structure of an anti-interleukin-2 monoclonal antibody Fab complexed with an antigenic nonapeptide.
|
| |
Protein Sci,
10,
1514-1521.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Rifai,
K.Fadden,
S.L.Morrison,
and
K.R.Chintalacharuvu
(2000).
The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes.
|
| |
J Exp Med,
191,
2171-2182.
|
 |
|
|
|
|
 |
B.W.Senior,
J.I.Dunlop,
M.R.Batten,
M.Kilian,
and
J.M.Woof
(2000).
Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases.
|
| |
Infect Immun,
68,
463-469.
|
 |
|
|
|
|
 |
M.A.Kerr
(2000).
Function of immunoglobulin A in immunity.
|
| |
Gut,
47,
751-752.
|
 |
|
|
|
|
 |
R.J.Pleass,
J.I.Dunlop,
C.M.Anderson,
and
J.M.Woof
(1999).
Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89.
|
| |
J Biol Chem,
274,
23508-23514.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |